Saving Sight continues to partner with KidSight, a Missouri-based 501(c)(3) nonprofit organization that provides free vision screenings for children. At our June 2021 board meeting, the Saving Sight board voted to donate $35,000 to KidSight to support their work. This brings the total amount Saving Sight has donated to KidSight during the 2020-2021 fiscal year to $65,000.
As an organization with a mission to change lives by saving sight, supporting organizations like KidSight with a similar mission is vital.
The KidSight program was founded in St. Louis, Missouri in 1995 as a part of Saving Sight with a handful of volunteers screening a few hundred children a year. Today, KidSight’s program has grown to screen the vision of more than 67,000 kids throughout Missouri each year with the help of trained staff and volunteers operating across the state. Using a photoscreening device, they quickly and noninvasively screen children ages 6 months to 6 years for common causes of childhood vision loss. KidSight then refers at-risk children to eye doctors for examination, necessary treatment and follow-up to ensure kids get the care they need. KidSight has held its own 501(c)(3) status since August 2016. You can learn more or make a donation to KidSight at www.kid-sight.org.
Wichita, Kan. (June 1, 2021) – Two Kansas-based eye banks have partnered, increasing their impact to save sight in communities throughout the state and beyond. As of June 1, Saving Sight and the Kansas Eye Bank & Cornea Research Center, Inc. have integrated operations and now operate a Wichita location as Kansas Eye Bank, a division of Saving Sight.
This partnership brings together two nonprofit organizations with a rich history of serving the community, ocular transplant physicians, vision researchers, and area hospitals. The two organizations have a shared mission to restore vision to individuals needing a corneal transplant while also fulfilling the wishes of Kansans to become eye tissue donors upon passing.
“We’re excited about what this new partnership means in providing sight to even more people across Kansas, the Midwest, and beyond,” said Tony Bavuso, CEO of Saving Sight.
Saving Sight provides donated corneal tissue for transplant, restoring sight to approximately 8 individuals each day. The addition of the Kansas Eye Bank’s Wichita facility to the Saving Sight system will add new donor hospitals to its network, setting the stage to increase the number of tissues the nonprofit provides to physicians for transplantation. Additionally, the new partnership will allow Saving Sight to expand its efforts in supporting the choice of eye donors and their families to leave a legacy through eye tissue donation.
Saving Sight currently operates four other facilities apart from its headquarters in Kansas City, Mo., including locations in St. Louis, Columbia, Mo., Springfield, Mo., and Springfield, Ill.
About Saving Sight
Saving Sight is a 501(c)(3) nonprofit organization with a mission to change lives by saving sight. Founded in 1960, Saving Sight has grown to become one of the nation’s leading eye banks and is focused on providing innovative solutions to its clinical partners. Headquartered in Kansas City, Mo., Saving Sight facilitates eye donation in Missouri, Kansas, and Illinois, impacting the lives of those both near and far through transplantation.
Joseph Tauber, MD, presented on the use of serum tears in March
On Wednesday, March 3, ophthalmologist and Saving Sight Medical Director, Joseph Tauber, MD, presented on using serum tears therapy in ocular surface disease. The webinar was hosted by Vital Tears, an organization that offers autologous serum tears to eye care professionals and their patients throughout the nation. Saving Sight is a co-founder of Vital Tears, and processes all orders for the serum tears in its laboratory.
Dr. Tauber has an in-depth understanding of the use of serum tears in patients with ocular surface disease, as he was an early adopter of using Vital Tears in his practice. During the webinar Dr. Tauber shared insights into how serum tears fit into a treatment plan for dry eye disease, as well how Vital Tears has simplified the process for patients and physicians.
In addition to serving as Saving Sight’s medical director, Dr. Tauber is a recognized authority in the field of ocular surface diseases, including dry eye. Avidly involved in research for almost three decades, Dr. Tauber has been a principal investigator in over 125 research studies of high-risk corneal transplantation, inflammation and allergic eye diseases, corneal infectious diseases and numerous studies related to dry eye syndrome.
If you’re interested in learning more about the innovative approach that Vital Tears is taking in partnership with Saving Sight to restore sight, visit www.vitaltears.org.